Chronic toxicity and carcinogenicity studies of chromium picolinate monohydrate administered in feed to F344/N rats and B6C3F1 mice for 2 years

Food and Chemical Toxicology

Volumn 47, Issue 4, 2009, Pages 729-733

  Stout, M D ^a   Nyska, A ^b   Collins, B J ^a   Witt, K L ^a   Kissling, G E ^a   Malarkey, D E ^a   Hooth, M J ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b Timrat   (Israel)

Author keywords

Body weight; Diet; National Toxicology Program; Preputial gland; Supplement; Trivalent chromium

Indexed keywords

CHROMIUM; CHROMIUM PICOLINATE; PICOLINIC ACID;

ADENOMA; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CANCER INCIDENCE; CHRONIC TOXICITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG CARCINOGENICITY; FEMALE; FISCHER 344 RAT; FOOD INTAKE; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; OUTCOME ASSESSMENT; PENIS CANCER; PREPUTIAL GLAND; RAT; SURVIVAL;

ANIMALS; CARCINOGENICITY TESTS; FEMALE; MALE; MICE; NEOPLASMS, EXPERIMENTAL; PICOLINIC ACIDS; RATS; RATS, INBRED F344; TOXICITY TESTS, CHRONIC;

MUS; RATTUS;

EID: 60849121392     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2009.01.006     Document Type: Article

References (54)

1. Agency for Toxic Substances and Disease Registry (ATSDR), 2000. Toxicological Profile for Chromium. US Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry.
2. Anderson R.A. Essentiality of chromium in humans. Sci Total Environ. 86 (1989) 75-81
3. Anderson R.A. Chromium, glucose intolerance and diabetes. J. Am. Coll. Nutr. 17 (1998) 548-555
4. Anderson R.A., Bryden N.A., Polansky M.M., and Gautschi K. Dietary chromium effects on tissue chromium concentrations and chromium absorption in rats. J. Trace Elem. Exp. Med. 9 (1996) 11-25
5. Anderson R.A., Bryden N.A., and Polansky M.M. Lack of toxicity of chromium chloride and chromium picolinate in rats. J. Am. Coll. Nutr. 16 (1997) 273-279
6. Andersson M.A., Petersson Grawé K.V., Karlsson O.M., Abramsson-Zetterberg L.A., and Hellman B.E. Evaluation of the potential genotoxicity of chromium picolinate in mammalian cells in vivo and in vitro. Food Chem. Toxicol. 45 (2007) 1097-1106
7. Amrani S., Rizki M., Creus A., and Marcos R. Genotoxic activity of different chromium compounds in larval cells of Drosophila melanogaster, as measured in the wing spot test. Environ. Mol. Mutagen. 34 (1999) 47-51
8. Bailer A.J., and Portier C.J. Effects of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small samples. Biometrics 44 (1988) 417-431
9. Bailey M.M., Boohaker J.G., Jernigan P.L., Townsend M.B., Sturdivant J., Rasco J.F., Vincent J.B., and Hood R.D. Effects of pre- and postnatal exposure to chromium picolinate or picolinic acid on neurological development in CD-1 mice. Biol. Trace Elem. Res. 124 (2008) 70-82
10. Bailey M.M., Boohaker J.G., Sawyer R.D., Behling J.E., Rasco J.F., Jernigan J.J., Hood R.D., and Vincent J.B. Exposure of pregnant mice to chromium picolinate results in skeletal defects in their offspring. Birth Defects Res. 77 (2006) 244-249
11. Boorman G.A., Montgomery Jr. C.A., Eustis S.L., Wolfe M.J., McConnell E.E., and Hardisty J.F. Quality assurance in pathology for rodent carcinogenicity studies. In: Milman H.A., and Weisburger E.K. (Eds). Handbook of Carcinogen Testing (1985), Noyes Publications, Park Ridge, NJ 345-357
12. Bridgewater L.C., Manning F.C.R., Woo E.S., and Patierno S.R. DNA polymerase arrest by adducted trivalent chromium. Mol. Carcinog. 9 (1994) 122-133
13. Cefalu W.T., and Hu F. Role of chromium in human health and in diabetes. Diabetes Care 27 (2004) 2741-2751
14. Clodfelder B.J., Emamaullee J., Hepburn D.D.D., Chakov N.E., Nettles H.S., and Vincent J.B. The trail of chromium(III) in vivo from the blood to the urine: the roles of transferrin and chromodulin. J. Biol. Inorg. Chem. 6 (2001) 608-617
15. Code of Federal Regulations (CFR) 21, Part 58.
16. Copeland-Haines D., and Eustis S.L. Specialized sebaceous glands. In: Boorman G.A., Eustis S.L., Elwell M.R., Montgomery Jr. C.A., and MacKenzie W.F. (Eds). Pathology of the Fischer Rat. Reference and Atlas (1990), Academic Press, Inc., San Diego 279-293
17. Cox D.R. Regression models and life-tables. J. R. Stat. Soc. B34 (1972) 187-220
18. Evans G.W., and Pouchnik D.J. Composition and biological activity of chromium-pyridine carboxylate complexes. J. Inorg. Biochem. 49 (1993) 177-187
19. Federal Trade Commission, 1996. Chromium picolinate cases. Available at URL: .
20. Gudi R., Slesinski R.S., Clarke J.J., and San R.H. Chromium picolinate does not produce chromosome damage in CHO cells. Mutat. Res. 587 (2005) 140-146
21. Hepburn D.D., and Vincent J.B. In vivo distribution of chromium from chromium picolinate in rats and implications for the safety of the dietary supplement. Chem. Res. Toxicol. 15 (2002) 93-100
22. Hepburn D.D., and Vincent J.B. Tissue and subcellular distribution of chromium picolinate with time after entering the bloodstream. J. Inorg. Biochem. 94 (2003) 86-93
23. Institute of Medicine (IOM), 2001. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Food and Nutrition Board, Institute of Medicine. National Academy Press, Washington, DC.
24. Ivankovic S., and Preussmann R. Absence of toxic and carcinogenic effects after administration of high doses of chromic oxide pigment in subacute and long-term experiments in rats. Food Cosmet. Toxicol. 13 (1975) 347-351
25. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53 (1958) 457-481
26. Komorowski J.R., Greenberg D., and Juturu V. Chromium picolinate does not produce chromosome damage. Toxicol. In Vitro 22 (2008) 819-826
27. MacKenzie R.D., Byerrum R.U., Decker C.F., Hoppert C.A., and Langham R.F. Chronic toxicity studies. II. Hexavalent and trivalent chromium administered in drinking water to rats. AMA Arch. Ind. Health 18 (1958) 232-234
28. Mirasol, F., 2000. Chromium picolinate market sees robust growth and high demand. Available at URL: .
29. Maronpot R.R., and Boorman G.A. Interpretation of rodent hepatocellular proliferative alterations and hepatocellular tumors in chemical safety assessment. Toxicol. Pathol. 10 (1982) 71-80
30. National Toxicology Program (NTP), 2008. Toxicology and Carcinogenesis Studies of Chromium Picolinate Monohydrate (CAS No. 27882-76-4) in F344/N Rats and B6C3F1 Mice (Feed Studies). Technical Report Series No. 556, NIH Publication No. 08-5897. National Institutes of Health, Public Health Service, US Department of Health and Human Services, Research Triangle Park (draft).
31. NIH (National Institutes of Health), 2007. Dietary Supplement Fact Sheet: Chromium. Office of Dietary Supplements, NIH Clinical Center. Available at URL: .
32. O'Brien T.J., Ceryak S., and Patierno S.R. Complexities of chromium carcinogenesis: role of cellular response, repair, and recovery mechanisms. Mutat. Res. 533 (2003) 3-36
33. Olin K.L., Stearns D.M., Armstrong W.H., and Keen C.L. Comparative retention/absorption of 51chromium (51Cr) from 51Cr chloride, 51Cr nicotinate and 51Cr picolinate in a rat model. Trace. Elem. Electroly. 11 (1994) 182-186
34. Piegorsch W.W., and Bailer A.J. Statistics for Environmental Biology and Toxicology (1997), Chapman and Hall, London Section 6.3.2
35. Portier C.J., and Bailer A.J. Testing for increased carcinogenicity using a survival-adjusted quantal response test. Fundam. Appl. Toxicol. 12 (1989) 731-737
36. Quievryn G., Messer J., and Zhitkovich A. Lower mutagenicity but higher stability of Cr-DNA adducts formed during gradual chromate activation with ascorbate. Carcinogenesis 27 (2006) 2316-2321
37. Reynolds M., Stoddard L., Bespalov I., and Zhitkovich A. Ascorbate acts as a highly potent inducer of chromate mutagenesis and clastogenesis: linkage to DNA breaks in G2 phase by mismatch repair. Nucleic Acids Res. 35 (2007) 465-476
38. Rhodes M.C., Hébert C.D., Herbert R.A., Morinello E.J., Roycroft J.H., Travlos G.S., and Abdo K.M. Absence of toxic effects in F344/N rats and B6C3F1 mice following subchronic administration of chromium picolinate monohydrate. Food. Chem. Toxicol. 43 (2005) 21-29
39. Schroeder H.A., Balassa J.J., and Vinton Jr. W.H. Chromium, lead, cadmium, nickel and titanium in mice: effect on mortality, tumors and tissue levels. J. Nutr. 83 (1964) 239-250
40. Schroeder H.A., Balassa J.J., and Vinton Jr. W.H. Chromium, cadmium and lead in rats: effects on life span, tumors and tissue levels. J. Nutr. 86 (1965) 51-66
41. Slesinski R.S., Clarke J.J., San R.H., and Gudi R. Lack of mutagenicity of chromium picolinate in the hypoxanthine phosphoribosyltransferase gene mutation assay in Chinese hamster ovary cells. Mutat. Res. 585 (2005) 86-95
42. Snow E.T. Effects of chromium on DNA replication in vitro. Environ. Health Perspect. 102 (1994) 41-44
43. Snow E.T., and Xu L.-S. Chromium(III) bound to DNA templates promotes increased polymerase processivity and decreased fidelity during replication in vitro. Biochemistry 30 (1991) 11238-11245
44. Stallings D., and Vincent J.B. Chromium: a case study in how not to perform nutritional research. Curr. Top. Nutraceut. Res. 4 (2006) 89-112
45. Stearns D.M. Is chromium a trace essential metal?. Biofactors 11 (2000) 149-162
46. Stearns D.M., Wise Sr. J.P., Patierno S.R., and Wetterhahn K.E. Chromium(III) picolinate produces chromosome damage in Chinese hamster ovary cells. FASEB J. 9 (1995) 1643-1648
47. Stearns D.M., Belbruno J.J., and Wetterhahn K.E. A prediction of chromium(III) accumulation in humans from chromium dietary supplements. FASEB J. 9 (1995) 1650-1657
48. Stearns D.M., Silveira S.M., Wolf K.K., and Luke A.M. Chromium(III) tris(picolinate) is mutagenic at the hypoxanthine (guanine) phosphoribosyltransferase locus in Chinese hamster ovary cells. Mutat. Res. 513 (2002) 135-142
49. Tarone R.E. Tests for trend in life table analysis. Biometrika 62 (1975) 679-682
50. Vincent J.B. The bioinorganic chemistry of chromium(III). Polyhedron 20 (2001) 1-26
51. Whittaker P., San R.H., Clarke J.J., Seifried H.E., and Dunkel V.C. Mutagenicity of chromium picolinate and its components in Salmonella typhimurium and L5178Y mouse lymphoma cells. Food Chem. Toxicol. 43 (2005) 1619-1625
52. Witt K.L., Knapton A., Wehr C.M., Hook G.J., Mirsalis J., Shelby M.D., and MacGregor J.T. Micronucleated erythrocyte frequency in peripheral blood of B6C3F1 mice from short-term, prechronic, and chronic studies of the NTP Carcinogenesis Bioassay Program. Environ. Mol. Mutagen. 36 (2000) 163-194
53. Zeiger E., Anderson B., Haworth S., Lawlor T., and Mortelmans K. Salmonella mutagenicity tests: V. Results from the testing of 311 chemicals. Environ. Mol. Mutagen. 19 Suppl. 21 (1992) 2-141
54. Zhitkovich A. Importance of chromium - DNA adducts in mutagenicity and toxicity of chromium (VI). Chem. Res. Toxicol. 18 (2005) 3-9